A survey of palivizumab for infants with cystic fibrosis in the UK
- PMID: 17185451
- PMCID: PMC2083141
- DOI: 10.1136/adc.2006.0105338
A survey of palivizumab for infants with cystic fibrosis in the UK
Conflict of interest statement
Competing interests: None declared.
References
-
- The IMpact RSV Study Group Palivizumab, a humanized respiratory syncytial virus monoclonal antibody, reduces hospitalization from respiratory syncytial virus infection in high‐risk infants. Pediatrics 1998102531–537. - PubMed
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical